Onxeo Announces its Financial Agenda for 2018
Paris (France), January 23, 2018 - 5:45 pm CET - Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO - FR0010095596), ('Onxeo' or the 'Company'), a biotechnology company specializing in the development of innovative drugs in oncology, in particular against rare or resistant cancers, today announced its financial agenda for 2018.
Event | Date* |
Full-year 2017 results | Thursday, March 29, 2018 |
Q1 2018 financial information | Friday, May 4, 2018 |
Shareholders' general meeting | Wednesday, May 16, 2018 |
Half-year 2018 results | Friday, July 27, 2018 |
Q3 2018 financial information | Thursday, October 25, 2018 |
* This preliminary agenda may be modified. Press releases are published after financial markets close.
180123_ONXEO_Agenda-2018_EN
Onxeo SA published this content on 23 January 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 23 January 2018 16:24:02 UTC.
Original documenthttp://www.onxeo.com/en/financial-agenda-2018/
Public permalinkhttp://www.publicnow.com/view/504C15FDEA45C052C37F90A1ABF63D21065969BA